East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia
CompletedPhase 2NCT01922466
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the efficacy and safety of east-west collaborative treatment using bee venom acupuncture and NSAIDs on pain intensity, functional status and quality of life of patients with chronic cervicalgia
Study details
- Official title
- Clinical Research on the Efficacy and Safety of East-West Collaborative Treatment Using NSAIDs and BV on Chronic Cervical Pain; A Randomized, Controlled, Parallel, Pilot Study
- Conditions
- Chronic Non-specific, Uncomplicated Neck Pain
- Interventions
- Procedure: Bee Venom Acupuncture
- Drug: Loxoprofen
- Sponsor
- Kyunghee University Medical Center
- Collaborators
- Kyung Hee University Hospital at Gangdong; Kyunghee University; Korea Institute of Oriental Medicine
- Start date
- 2013-07
- Primary completion
- 2014-03
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age between 18 and 65 years * nonspecific, uncomplicated, chronic neck pain over 3 months * volunteer can read and write in Korean, providing written informed consent Exclusion Criteria: * exhibited abnormalities on neurological examination * radicular pain * serious spinal disorders including malignancy, vertebral fracture, spinal infection or inflammatory spondylitis * other chronic diseases that could affect or interfere with the therapeutic outcomes including cardiovascular disease, diabetic neuropathy, active hepatitis, fibromyalgia, rheumatoid arthritis, dementia or epilepsy * previous spinal surgery or scheduled procedures during the study * painful conditions induced by traffic accidents * a substantial musculoskeletal problem generating pain from an area other than the neck * conditions for which administration of BVA might not be safe including clotting disorders, administration of an anticoagulant agent, pregnancy and seizure disorders * a documented hypersensitive reaction to previous BVA treatments, bee stings or insect bites * positive reaction observed during a skin hypersensitivity test * severe psychiatric or psychological disorders * current use of corticosteroids, narcotics, muscle relaxants or herbal medicines to treat neck pain or any medication considered inappropriate by the investigator * pending lawsuits or receipt of compensation due to neck pain.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01922466